Here are short takes on major medical and pharma stories in our new HEALTH IN A HURRY, with context on why this week’s health news matters.
Will Mounjaro (tirzepatide) become the next big weight loss drug? How does it compare to Ozempic? What side effects should you be aware of?
Surgery while on Ozempic or Wegovy or other GLP-1 agonists such as Victoza, Saxenda, or Mounjaro requires special caution. Beware aspiration!
Medicare Part D will now pay for Wegovy (semaglutide) to help millions of overweight people reduce their risk of heart attacks and strokes.
Almost everyone has heard of Ozempic and Wegovy. These drugs contain semaglutide, just like Rybelsus? Are kidney stones and Rybelsus a thing?
The FDA approved Mounjaro (tirzepatide) 5/13/22 for type 2 diabetes and Zepbound for weight management on 11/8/23. Does it also lower BP?
This reader eats to live & no longer lives to eat thanks to semaglutide. She also has diabetes. Should MDs prescribe Ozempic for weight loss?
Ozempic and Wegovy are in short supply. Weight loss is a BIG market! What do you think about the name Zepbound? It's the latest obesity drug!
Ozempic and Wegovy (semaglutide) are making Novo Nordisk wealthy. Americans are fat and they want a quick fix! They pay more than anyone else
The best way to lose weight remains an ongoing dispute. We have been denounced and praised for discussing a Wegovy weight loss strategy.